ASSESSMENT OF THE EFFECTIVENESS OF INDIVIDUAL DOSIMETRIC CONTROL OF PERSONNEL WORKING WITH ¹³¹I UNDER CONDITIONS OF RADIONUCLIDE THERAPY AND DIAGNOSTICS: ANALYSIS OF REGULATORY LIMITATIONS AND REDUCTION OF OCCUPATIONAL RISKS

This study investigates the characteristics of individual dose formation in Category A personnel (n = 20) working with radioactive iodine-131 (¹³¹I) under conditions of radionuclide therapy and diagnostics. The aim of the study was to assess the informative value of individual dosimetric monitoring for the analysis of both external and internal exposure in the real clinical practice of the Center of Nuclear Medicine and Oncology of the Abai Region. Based on a retrospective analysis of individual dosimetric monitoring data and in vivo spectrometry measurements, the variability of ¹³¹I activity in the thyroid gland of personnel and its contribution to the annual effective dose were evaluated. It was demonstrated that, when radiation safety regulations are complied with, occupational dose levels remain significantly below established regulatory limits. At the same time, differences in internal exposure indicators were found to be more strongly associated with individual clinical and physiological characteristics of thyroid function than with the conditions of professional activity. The obtained results demonstrate that individual dosimetric monitoring can be considered not only a regulatory tool but also an analytical instrument that enables deeper interpretation of dose formation mechanisms and supports the justification of further optimization of radiation protection systems in accordance with the ALARA principle.

1. Rais J., Gambhir S., Dixit M. The role of 131I in the treatment and management of thyroid cancer // Current Radiopharmaceuticals – 2026 – 19 (1) – art. no. 100009. doi: 10.1016/j.craph.2025.100009

2. F. Eilsberger, A. Pfestroff // Theranostics in thyroid cancer - PET Clin. – 2021. - 16 (3) - pp. 375-382. doi: 10.1016/j.cpet.2021.03.007

3. Fakih TM, Novitasari D, Syaifudin M, Meiyanto E, Astirin OP, Mohd Gazzali A, Muchtaridi M. Role of Radioiodine in Cancer Therapy: A Review of the Design and Challenges in Selecting Radioligands from Natural Sources. // Drug Des Devel Ther. – 2025 – 19 – PP. 8009-8039. doi: 10.2147/DDDT.S524612.

4. Liu G, Li Y, Zhang H, Zhang X, Liu YY, Wu XQ, Niu LM, Zhang R. Thyroid dose assessments due to inhalation of 131I for nuclear medicine workers. // Front Public Health. – 2022. - 10:1027782. doi: 10.3389/fpubh.2022.1027782.

5. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103 // Ann ICRP. – 2007. - 37(2-4) - 1-332. doi: 10.1016/j.icrp.2007.10.003. PMID: 18082557.

6. Krajewska G, Krajewski P. Evaluation of internal exposure of nuclear medicine staff working with radioiodine in Poland. // Int J Occup Med Environ Health. – 2023 - 36(5) – PP. 587-595. doi: 10.13075/ijomeh.1896.02136.

7. ICRP, 2017. Occupational Intakes of Radionuclides: Part 3. ICRP Publication 137. Ann. ICRP 46(3/4). https://www.icrp.org/page.asp?id=5

8. ICRP, 2015. Occupational Intakes of Radionuclides: Part 1. ICRP Publication 130. Ann. ICRP 44(2). https://journals.sagepub.com/doi/pdf/10.1177/ANIB_44_2

9. Radiation Protection and Safety in Medical Uses of Ionizing Radiation, IAEA Safety Standards, safety standards series, ISSN 1020-525X ; no. SSG-46, IAEA, Vienna, 2018 https://www-pub.iaea.org/MTCD/Publications/PDF/PUB1775_web.pdf

10. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources, effects and risks of ionizing radiation UNSCEAR 2024 Report. // ANNEX A: Second primary cancer after radiotherapy. - Volume I https://www.unscear.org/unscear/uploads/documents/unscear-reports/UNSCEAR_2024_Report_Vol.I.pdf

11. Mench A, Winters C, Mittra E, Szidonya L, Hess C, Barbon D, Mallak N. Navigating Radiation Safety After Radiopharmaceutical Therapies: Proposed Workflow and Essential Guidelines for Nonspecialists. // J Nucl Med. – 2025. – 66(7) – P. 990-994. doi: 10.2967/jnumed.124.268522.

12. On Radiation Safety of the Population: Law of the Republic of Kazakhstan No. 219-I dated April 23, 1998 (as amended and supplemented as of 2025). – Text: electronic // "Adilet" Information and Legal System of Regulatory Legal Acts of the Republic of Kazakhstan. – URL: https://adilet.zan.kz (accessed: 18.12.2025).

13. On Approval of Sanitary Rules "Sanitary and Epidemiological Requirements for Ensuring Radiation Safety" : Order of the Minister of Healthcare of the Republic of Kazakhstan No. KR DSM-275/2020 dated December 15, 2020 (as amended and supplemented as of 2025). – Text: electronic // "Adilet" Information and Legal System of Regulatory Legal Acts of the Republic of Kazakhstan. – URL: https://adilet.zan.kz (accessed: 18.12.2025).

14. ICRP, 2015. Radiation Dose to Patients from Radiopharmaceuticals: A Compendium of Current Information Related to Frequently Used Substances. ICRP Publication 128. – Ann. ICRP 44(2S).

15. Радиационная защита и безопасность источников излучения: Международные основные нормы безопасности : серия норм МАГАТЭ по безопасности № GSR Part 3. – Вена : МАГАТЭ, 2014. – 519 с.

16. Radiation Protection and Safety in Medical Uses of Ionizing Radiation: Specific Safety Guide No. SSG-46. – Vienna: International Atomic Energy Agency (IAEA), 2019. – P. 318

17. Yoshitomi H, Nishino S, Tanimura Y, Takahashi M. A study of a calibration technique for a newly developed thyroid monitor and its uncertainties due to body size for radioiodine measurements. // Radiat Meas. – 2020 - 133:106279. doi: 10.1016/j.radmeas.2020.106279.

18. Struelens L, Aalbersberg E, Beels L, Cherbuin N, D'Asseler Y, De Monte F. [et all.] How much do 68Ga-, 177Lu- and 131I-based radiopharmaceuticals contribute to the global radiation exposure of nuclear medicine staff? // EJNMMI Phys. – 2024 - 11(1):95. doi: 10.1186/s40658-024-00695-3.

19. CAPTUS 4000e Thyroid Uptake System. Operator’s Manual: [Руководство оператора системы захвата щитовидной железы CAPTUS 4000e]. – Ramsey, NJ: Capintec, Inc., 2015. – P. 240

20. On Approval of Hygienic Standards for Ensuring Radiation Safety: Order of the Minister of Healthcare of the Republic of Kazakhstan No. KR DSM-71 dated August 2, 2022. – Text: electronic // "Adilet" Information and Legal System of Regulatory Legal Acts of the Republic of Kazakhstan. – URL: https://adilet.zan.kz (accessed: 18.12.2025).

21. On Approval of Sanitary Rules "Sanitary and Epidemiological Requirements for Radiation-Hazardous Objects" : Order of the Minister of Healthcare of the Republic of Kazakhstan No. KR DSM-90 dated August 25, 2022. – Text: electronic // "Adilet" Information and Legal System of Regulatory Legal Acts of the Republic of Kazakhstan. – URL: https://adilet.zan.kz/rus/docs/V2200029292 (accessed: 18.12.2025).